Skip to main content

Advertisement

Contact Jasmin B Kuemmerle-Deschner

From: Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)

Contact corresponding author